TrialX was invited to the White House Eisenhower Executive Office Building (EEOB) on 28th of February, 2019 to present the AI based digital tools we developed as part of the The Opportunity Project (TOP) Health sprint.
TrialX participated in the HHS Innovation Initiative organized by the Office of the Chief Technology Officer and Presidential Innovation Fellows, to create digital tools based on Artificial Intelligence (AI) and open government data.
As part of the TOP Health sprint, GLA and TrialX’s Lyme Tracker App successfully addressed the two challenges posed - to create digital tools to increase access to experimental treatments and to use the power of the crowd to solve Lyme disease.
Dr. David Fajgenbaum of University of Pennsylvania who leads the charge against his rare condition talks about his incredible journey unraveling Castleman Disease.
The news comes nearly 12 years to the day after the first patient known to be cured, a feat that researchers have long tried, and failed, to duplicate.
Doctors welcomed federal approval of this new, fast-acting nasal spray for depression, but also expressed concerns about its administration, cost and long-term effects.
The “Washington My Health My Data Act” (Substitute House Bill 1155) is an act that establishes strict regulations on the collection, sharing, and selling of consumer health data in Washington. Signed On April 27th, the act…
We are thrilled to share some exciting news with you! Our innovative work in the field of space health research has been prominently featured as – not one, but two groundbreaking papers – in the latest edition…
The DIA 2024 conference concluded, and we are thrilled to share the highlights of our participation. A prominent event – attended by 4K+ people and featuring 220 sessions with more than 500 speakers across 13 engaging…